Tryten Screening Assistant Captures Temperature and More

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

“The current phase of responding to the novel virus COVID-19 requires a concerted effort to mitigate community spread this summer and into the fall. The CDC has provided guidance for reopening that includes screening employees, visitors and residents (or patients) as they enter or leave facilities to help avoid unnecessary contact and spread of COVID-19. We are introducing the Tryten Screening Assistant to help capture temperature and facilitate the collection of screening questions,” said Dr. Deborah A. Jeffries, Global Director of Healthcare at Tryten.

“COVID-19 has placed many stressors in our lives and created a new set of healthcare challenges.  We will continue to do all we can to support efforts to combat the virus and support our healthcare community,” said Tony Janzen, CEO of Tryten.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles